Fierce Pharma

JANUARY 29, 2024

The start of the new year doesn’t seem to have dulled the zeal of Pfizer’s global cost-cutting campaign, which has already left hundreds of jobs in its wake. | Come mid-February, Pfizer will lay off some 52 employees at a facility in South San Francisco, according to a recent Worker Adjustment and Retraining Notification Act alert. The site is the former headquarters of Global Blood Therapeutics.

341

341

Pharmaceutical Technology

JANUARY 29, 2024

At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to continue to establish its place in the immunological space.

Healthcare 144

Healthcare Healthcare 144

Fierce Pharma

JANUARY 29, 2024

New legislation aimed at blocking a group of Chinese biopharma firms from tapping into U.S. federal funding has sent shares tumbling in recent days. | New legislation aimed at blocking a group of Chinese biopharma firms from tapping into U.S. federal funding has sent shares tumbling in recent days. WuXi Bio, for its part, says it's not affiliated with the military in China.

Biopharma 314

Biopharma 314

MedCity News

JANUARY 29, 2024

Science 37 rode the trends of Covid-19 technologies and SPAC mergers to a more than $1 billion valuation. But revenue for the decentralized clinical trials software firm stopped growing, and it’s now going private valued at just $38 million.

Biopharma 120

Biopharma Pharma 120

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 29, 2024

Grifols has filed a lawsuit against Gotham City that accuses the hedge fund of manipulating "the value of Grifols’ stock for their own monetary gain.

274

274

MedCity News

JANUARY 29, 2024

This month, the World Health Organization released new guidelines on the ethics and governance of LLMs in healthcare. Reactions from the leaders of healthcare AI companies have been mainly positive. However, one leader pointed out that fear or the risks associated with LLMs shouldn’t hinder innovation, and another noted that the guidance may have failed to mention a major topic.

Healthcare 121

Healthcare Healthcare Ethics Government 121

European Pharmaceutical Review

JANUARY 29, 2024

N-Nitrosamines By far the biggest issue bedevilling industry during 2023 was the continuing N-nitrosamine contamination saga, which was covered in the third issue of EPR 2023. 1 Some five years after the initial NDMA (N-nitrosodimethylamine) contamination issue 2 initially affecting valsartan drug substance, then other active pharmaceutical ingredients (APIs), eg, sartans, ranitidine, metformin, etc; the toxic short alkyl chain N-nitrosamine issue appears, if not resolved, then well on the way t

Pharmaceutical 111

Pharmaceutical Food and Drug Administration Medicine FDA 111

Pharmaceutical Commerce

JANUARY 29, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law PLLC, discusses recent moves by CVS and Express Scripts to follow Mark Cuban's drug plus model.

Pharma 110

Pharma 110

pharmaphorum

JANUARY 29, 2024

Spanish drugmaker Grifols has hit back at hedge fund Gotham City Research, which claimed it had fraudulently manipulated its financial reporting, with a lawsuit filed in New York. The complaint has been brought against Gotham City and co-founders Daniel Yu and Cyrus de Weck, along with other defendants, and accuses them of being “predatory short sellers…who illicitly profit from their rigged short-and-distort schemes.

109

109

Pharmaceutical Technology

JANUARY 29, 2024

The rapid sequencing of the SARS-CoV-2 and the subsequent development of mRNA vaccines led to the authorisation of the first of these vaccines in late 2020.

Leads 111

Leads 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JANUARY 29, 2024

Instacart and DispatchHealth recently launched a partnership that allows DispatchHealth to provide food interventions to patients in need of nutrition support.

Food 109

Food Patients 109

European Pharmaceutical Review

JANUARY 29, 2024

According to Medicines for Europe, the Munich District Court’s Supplementary Protection Certificate (SPC) manufacturing waiver , issued in Germany in October 2023, is “in conflict” with the objectives of the waiver. The organisation and its members are “strongly concerned” by the court’s first judgement of the waiver. SPC manufacturing waiver Aims and challenges First enacted in 2019, the goal of the SPC manufacturing waiver is to enable the manufacture of medicines, under certain conditions, du

Medicine 98

Medicine Manufacturing Competition Marketing 98

MedCity News

JANUARY 29, 2024

When it comes to AI, the consensus is that healthcare organizations have an opportunity right now to take an enterprise-wide approach that encompasses everything from workforce to infrastructure to governance and beyond. Here are these ten essential elements of an enterprise-wide AI strategy for healthcare organizations.

Government 105

Government Healthcare Healthcare Biopharma 105

pharmaphorum

JANUARY 29, 2024

Bristol-Myers Squibb is getting closer to offering a subcutaneous version of its cancer immunotherapy Opdivo to patients after it matched the current intravenous formulation in a head-to-head trial in kidney cancer.

Patients 102

Patients 102

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

JANUARY 29, 2024

In the published in 2023, the process and requirements for toxicological risk assessment of medical device constituents is outlined. Also covered in the guideline are “the methods and criteria used to assess whether exposure to a constituent is without appreciable harm”. As highlighted by the International Organization for Standardization (ISO), the process described in the standard is relevant to chemical characterisation, such as extractable data or leachable data ( E&L ), information obta

Food and Drug Administration 98

Food and Drug Administration Medical Safety Food 98

pharmaphorum

JANUARY 29, 2024

GSK has claimed EU approval of Omjjara for the treatment of splenomegaly or symptoms in adult myelofibrosis patients with moderate-to-severe anaemia

Patients 104

Patients 104

PharmaVoice

JANUARY 29, 2024

In addition to the chronic disease, the non-opioid drug may have applications in other painful conditions.

120

120

pharmaphorum

JANUARY 29, 2024

MSD’s Keytruda is the first cancer immunotherapy to improve survival when used as adjuvant therapy in renal cell carcinoma (RCC).

111

111

Advertisement

MedCity News

JANUARY 29, 2024

Sanofi and Synthekine will work together to develop cytokine therapies for inflammatory diseases. This new alliance comes as Sanofi is salvaging a different cytokine therapy that showed disappointing efficacy in Phase 2 after the pharma giant acquired it in a $2.5 billion deal.

Pharma 99

Pharma Biopharma 99

Pharmaceutical Technology

JANUARY 29, 2024

An eye-catching milestone in hand, Ascidian will begin the Phase I/II STELLAR study of ACDN-01 for Stargardt disease in H1 2024.

104

104

MedCity News

JANUARY 29, 2024

In response to emailed questions, Kismet Health Co-founders CEO Dr. Cierra Gromoff and COO Christie Sander talked about why they started the business.

106

106

Pharmaceutical Technology

JANUARY 29, 2024

The full potential of cell and gene therapies (CGTs) has not yet been discovered as these therapies promise life-changing treatments.

Pharmaceutical 97

Pharmaceutical 97

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

MedCity News

JANUARY 29, 2024

While the term ‘CPQ’ — Configure, Price, Quote — might seem distanced from direct patient care, these tools are, in fact, pivotal for a modern, patient-centric healthcare system. Far from being just business-centric, CPQ tools are a fundamental component in the healthcare delivery chain.

Healthcare 94

Healthcare Healthcare Patients 94

pharmaphorum

JANUARY 29, 2024

AstraZeneca and Daiichi Sankyo’s Enhertu could become the first therapy approved by the FDA for use in any HER2-positive cancer, regardless of its location in the body. The US regulator has started a priority review of the HER2-targeting antibody-drug conjugate (ADC) for the treatment of adults with unresectable or metastatic HER2-positive solid tumours who have been treated previously or have limited treatment options.

FDA 83

FDA 83

Pharmaceutical Technology

JANUARY 29, 2024

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.

Marketing 104

Marketing 104

pharmaphorum

JANUARY 29, 2024

Orion licenses digital pain therapeutic from Newel Health Phil.

109

109

Advertisement

Distribution

PharmaTimes

JANUARY 29, 2024

A total of 103,277 general and acute beds are now available to NHS patients

Patients 96

Patients 96

Pharmaceutical Technology

JANUARY 29, 2024

The US FDA has granted priority review to the sBLA for ENHERTU, a treatment developed by Daiichi Sankyo and AstraZeneca for solid tumours.

FDA 64

FDA 64

Scott’s Directories

JANUARY 29, 2024

Nurse practitioners (NPs) are increasingly vital in providing primary care, managing chronic conditions, and prescribing medications. This growing influence presents a significant opportunity for pharmaceutical companies. However, reaching the right NPs can be a challenge.MD Select offers a robust solution with its comprehensive nurse practitioner directory , designed to bridge the gap between pharmaceutical companies and NPs.

Pharma 52

Pharma Specialization Pharmaceutical Medical 52

Pharmaceutical Technology

JANUARY 29, 2024

The upcoming OCT West Coast 2024 conference will feature experts talking about emerging techologies, clinical trial operations for pharma and medical devices, and patient participation in studies.

Pharma 52

Pharma Medical Patients 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales